Development and Application of an Oral Care Protocol for Stroke Patients With Orotracheal Intubation

Develop a standardized oral care protocol for stroke patients undergoing orotracheal intubation based on evidence-based practice, and validate its effectiveness through clinical trials.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosed as a patient with stroke;Maintaining an oral tracheal tube insertion;The indwelling time of the oral tracheal tube should be at least 7 consecutive days;No oral diseases before intubation;Tooth count ≥ 10

Exclusion Criteria:The patient had been intubated for more than 48 hours before admission;Patients who have had their endotracheal tubes replaced during the procedure;Patients who were discharged halfway through their treatment

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Standardized oral care
Patients in this group will receive the standardized oral care protocol developed for post-intubation stroke patients. The intervention includes using [填入具体溶液,如 0.12% Chlorhexidine] solution, performed every 6 hours by trained nurses, following a specific assessment checklist to ensure thorough cleaning of the oral cavity and prevention of VAP.
Carry out oral care using the constructed standardized oral care plan
Active Comparator: Regular oral care
Patients in this group will receive the routine oral care procedures currently used in the department. This typically involves basic oral hygiene maintenance according to standard nursing guidelines without the specific standardized protocol interventions applied in the experimental group.
Carry out oral care using conventional methods

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Ventilator-Associated Pneumonia (VAP)
Time Frame: From intubation until extubation or discharge from ICU, up to 28 days.
The incidence of VAP will be assessed and compared between the two groups. Diagnosis will be based on clinical criteria including new or progressive radiographic infiltrates, purulent secretions, fever, and leukocytosis.
From intubation until extubation or discharge from ICU, up to 28 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

May 1, 2027

Study Registration Dates

First Submitted

July 1, 2026

First Submitted That Met QC Criteria

July 2, 2026

First Posted (Actual)

July 8, 2026

Study Record Updates

Last Update Posted (Actual)

July 8, 2026

Last Update Submitted That Met QC Criteria

July 2, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • KY-2026-099

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Standardized oral care protocol

3
Subscribe